Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Biosimilars (3)
70 Articles Available
3
3
Can't find what you're looking for? Try our
advanced search
.
Regulatory
Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA
PR-M01-18-NI-060
FDA Guidance
FDA Received Numerous Comments on Its Draft Guidance for Evaluating Biosimilarity
PAO-M01-18-NI-004
Biosimilars
Pfizer Receives FDA Approval for Remicade® Biosimilar
PAO-M12-17-NI-039
Drug Development
Chinese Biopharma Receives Series A Financing
PAO-M12-17-NI-031
Regulatory
FDA Approves New Pfizer Biosimilar
PR-M12-17-NI-010
Biosimilars
First Biosimilar to Treat Breast and Stomach Cancers Approved
PAO-M12-17-NI-007
Biosimilars
Boehringer Ingelheim’s Adalimumab Biosimilar Wins First EU Approval
PAO-M11-17-NI-045
Biosimilars
Amgen To Co-Develop Biosimilars for Chinese Market with Simcere Pharmaceutical Group
PAO-M10-17-NI-007
Biosimilar
FDA Approves First Biosimilar Treatment for Multiple Cancers
PAO-M09-17-NI-030
Biosimilar
Another Biosimilar Gets FDA Nod
PAO-M09-17-NI-011
FDA
The FDA Reauthorization Act Passes the U.S. Senate
PAO-M08-17-NI-026
Biosimilars
FDA Approves Celltrion/Teva BLA for Rituximab Biosimilar
PAO-M07-17-NI-006
Biosimilar
Biosimilar Manufacturers Get Favorable Decision from US Supreme Court
PAO-M06-17-NI-017
Acquisition
Fresenius Kabi Expands its Generics and Biosimilars Businesses
PAO-M05-17-NI-006
Biosimilar Era Begins to Blossom
PAO-M04-17-NI-027
Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization
POP-M03-17-NI-001
The Rise of Biosimilars
PMO-M12-NI-16-001
Biopharma’s Ascendant Supply Chain Reveals its Present Potential & Future Promise
PAP-Q02-16-FA-001
Biosimilars: Are We on the Edge of a New Era of Biologics?
PAP-Q02-16-RT-002
Will Biosimilars Make a Difference for the CMO/CDMO Market?
POP-M11-15-NI-001
Be Innovative! Maneuvering the Global Pharmaceutical Market
PAP-Q4-15-NO-001
Four Keys to Successful Biopharmaceutical Outsourcing: Technical Expertise, Quality, Reliability and Timeliness
PAP-APR-S01-CL-001
«
3
3
.svg)
